Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by skyhawk1on Aug 25, 2020 11:00pm
197 Views
Post# 31453584

RE:TLT Newspaper Article

RE:TLT Newspaper Article
oilgeo wrote: There was an article in the Winnipeg Free Press about TLT's collaboration with Dr. Coombs. I have not seen it written about here - perhaps because Theralase is spelled incorrectly as Theralese (talk about getting no respect). The article is a terrific endorsement for the technology from a scientist who prior to this collaboration had no connection to the company. Here is an example:

If successful, Theralese hopes to commercialize the technology for mass-scale production as early as late 2021.

Dr. Kevin Coombs, a leading microbiologist at U of M who’s spearheading the research, says he’s never seen anything like it.

"This technology is showing absolutely amazing high efficacy kill rates, both with and without stimulation," he said.
And there is this:
"I think it’s also very special that we don’t really even need to insert the PDCs directly inside a human being," he said. "We can take samples of blood and saliva to treat the virus in it and then safely insert that back in — isolating the fear of any toxicity entering the body."
The newspaper site has a free subscription - perhaps someone can post the link. I am not a regular poster and i am having difficulty attaching the link.  
 



Thanks for sharing! VERY POSITIVE STATEMENTS made about our TLD -1433 PDCs & our investment in this article! Very ENCOURAGING indeed.
<< Previous
Bullboard Posts
Next >>